Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX), a specialty pharmaceutical company focused on developing safe and effective approved medicines targeting orphan ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Management Comments Trader Talk

Catyalyst Pharmaceutical Partners (CPRX) Reports In-Line Q3 EPSNovember 14, 2013 8:05 AM